A patient who was on aspirin for a long period was selected for an elective surgery. Which of the following should be done next in this patient?
First, I need to recall how aspirin works. Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, which are crucial for prostaglandin synthesis. This leads to reduced thromboxane A2, a key platelet aggregator. Since platelet function is suppressed, stopping aspirin before surgery might help reduce bleeding risk.
But wait, when should you stop aspirin? The half-life of aspirin is short, but since the drug irreversibly inhibits platelets, the effect lasts until new platelets are produced. Platelet turnover is about 7-10 days. So, if the surgery is elective, stopping aspirin a week or two prior could allow platelet function to recover.
Now, looking at the options. The correct answer would involve stopping aspirin pre-surgery. But if the patient is on aspirin for a critical condition like a recent MI or stent placement, stopping could be risky. So, the decision depends on the balance between bleeding and clotting risks.
The incorrect options might suggest continuing aspirin, which is wrong unless there's a high thrombotic risk. Other options might involve bridging therapy with other antiplatelet agents or anticoagulants, which isn't standard here. Maybe checking platelet function tests isn't necessary because the mechanism is well-known.
So the key is to stop aspirin 7-10 days before surgery unless contraindicated. That's the clinical pearl here. The answer should be stopping aspirin a week before surgery.
**Core Concept**
Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1) in platelets, suppressing thromboxane A2 synthesis and impairing platelet aggregation. This antithrombotic effect persists until new platelets are produced (~7–10 days), necessitating discontinuation before elective surgery to reduce bleeding risk.
**Why the Correct Answer is Right**
Discontinuing aspirin 7–10 days pre-surgery allows platelet function to recover, minimizing intraoperative and postoperative bleeding. This is critical for elective procedures where the risk of hemorrhage outweighs thrombotic risks. No bridging therapy is required for aspirin, unlike reversible anticoagulants such as warfarin or heparin.
**Why Each Wrong Option is Incorrect**
**Option A:** Continuing aspirin increases bleeding risk unnecessarily.
**Option B:** Administering vitamin K is irrelevant; aspirin does not interfere with vitamin K-dependent clotting factors.
**Option D:** Platelet transfusions are reserved for acute bleeding or life-threatening conditions, not routine surgery.
**Clinical Pearl / High-Yield Fact**
Remember the **7–10 day rule** for aspirin discontinuation pre-surgery. For urgent procedures, balance bleeding vs. thrombotic risks—do not stop aspirin abruptly in patients with recent myocardial infarction (<6 weeks) or coronary stents (<1 month).
**Correct Answer: C. Discontinue aspirin 7–10 days prior to surgery**